JPRN-UMIN000019446招募中2 期
A study of biomarkers that predict efficacy of or resistance to trastuzumab emtansine for patients with HER2-positive non-small cell lung cancer - Biomarker study of T-DM1 for HER2-positive non-small cell lung cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •There are no special instruction regarding this section.
研究者
相似试验
招募中
不适用
Exploration of biomarkers to predict the efficacy of immune checkpoint inhibitors in gastric cancer using cell-free RNA.gastric cancerJPRN-UMIN000047448Kyushu University Hospital, Department of Surgery and Science42
已完成
不适用
Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumorsPatients with bone metastases newly treated by zoledronic acidJPRN-UMIN000018556agoya University Graduate School and School of Medicine27
已完成
不适用
Research for biomarkers to predict the effectiveness of denosumab in metastatic bone tumorsPatients with bone metastases newly treated by denosumabJPRN-UMIN000019700agoya University Graduate School and School of Medicine40
已完成
不适用
Exploratory study for biomarkers to predict efficacy and toxicity to Sorafenib in patients with advanced hepatocellular carcinomaHepatocellulara carcinomaJPRN-UMIN000008808ational Cancer Center Hospital100
招募中
Unknown
Exploration of biomarkers to predict the effects of anti TSLP antibody (Tezepelumab) in refractory asthma patients using comprehensive analyses of changes in gene expression in whole blood cellsSevere asthmaJPRN-UMIN000050670Department of Respiratory Medicine, University of Tsukuba50